REGEND007

· Regend Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGEND007, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy [EARLY_Phase 1]